A pharmacological activator of SIRT1, SRT1720, has been shown to extend mouse lifespan and healthspan [163] and to reverse endothelial inflammation, ROS production, and endothelial dysfunction in aged mice [164]. The gene discussed is SIRT1; the disease is endothelial dysfunction.